Aseon Labs, which came out of Y Combinator's 2026 spring cohort, has raised $10 million from Crane Venture Partners and ...
CAR-T-cell therapies are revolutionizing the treatment of blood cancers, and their full potential is still being explored in hundreds of clinical trials. In this therapy, a patient’s own T cells are ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...